Rhythm Biosciences (ASX:RHY) Accounts Payable & Accrued Expense : A$0.57 Mil (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Rhythm Biosciences Accounts Payable & Accrued Expense?

Rhythm Biosciences's quarterly accounts payable & accrued expense increased from Dec. 2022 (A$0.89 Mil) to Jun. 2023 (A$1.52 Mil) but then declined from Jun. 2023 (A$1.52 Mil) to Dec. 2023 (A$0.57 Mil).

Rhythm Biosciences's annual accounts payable & accrued expense declined from Jun. 2021 (A$1.21 Mil) to Jun. 2022 (A$0.63 Mil) but then increased from Jun. 2022 (A$0.63 Mil) to Jun. 2023 (A$1.52 Mil).

Rhythm Biosciences Accounts Payable & Accrued Expense Historical Data

The historical data trend for Rhythm Biosciences's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rhythm Biosciences Accounts Payable & Accrued Expense Chart

Rhythm Biosciences Annual Data

Trend

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

0.30

0.68

1.21

0.63

1.52

Rhythm Biosciences Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial								0.83	0.63	0.89	1.52	0.57

Rhythm Biosciences Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Rhythm Biosciences (ASX:RHY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Rhythm Biosciences Ltd (ASX:RHY) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

0RY:Germany

Address

30 Flemington Road, Bio21 Institute, Parkville, Melbourne, VIC, AUS, 3010

Website

https://www.rhythmbio.com

Rhythm Biosciences Ltd is a medical diagnostics technology company. It is engaged in developing and commercializing Australian medical diagnostics technology for sale to national and international markets. Its product includes ColoSTAT a proposed diagnostic blood test for screening for colorectal cancer. Geographically, the company operates only in Australia.

Rhythm Biosciences (ASX:RHY) Headlines

No Headlines